Science
Moderna and Merck’s Breakthrough in Cancer Treatment
Moderna and Merck have announced a landmark trial showing their mRNA therapy significantly reduces the risk of recurrent skin cancer. The combined drug works by boosting the immune system.
Coverage timeline — 1 article
Scientific American
The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells
2026-08-19 20:45 UTC